From July 1st, which diseases require mandatory vaccination?

From July 1st, 2026, mandatory vaccination will include HPV and many other diseases. Circular 13/2026/TT-BYT clearly specifies the diseases requiring vaccination. Let's explore the new list of diseases and vaccination procedures in this article.

HPV vaccination will be included in the mandatory immunization program from July 1, 2026.

According to the Circular, the national immunization information management system is an information system for managing, updating, storing, exploiting, and sharing immunization data nationwide, including subsystems for managing immunization recipients, vaccines, biological products, immunization procedures, statistics, reporting, and other subsystems as required by management.

Adverse events following vaccination are abnormal health occurrences, including local or systemic manifestations, that occur after vaccination and are not necessarily due to the use of the vaccine or biological product. These include common post-vaccination reactions and serious post-vaccination complications.

Common post-vaccination reactions are frequently observed clinical manifestations that resolve spontaneously and do not cause long-term effects, occurring after the administration of vaccines or biological products.

One of the notable points in Circular 13 is the regulation that diseases caused by the HPV (Human Papilloma Virus) in humans are included in the list of diseases requiring the use of vaccines and biological products in mandatory immunization through the Expanded Immunization Program.

Vaccination for children is part of the expanded immunization program.

Specifically, Article 3 of Circular 13/2026/TT-BYT stipulates the list of diseases requiring the use of vaccines and biological products in mandatory immunization, including:

1. Hepatitis B virus infection.

2. Tuberculosis.

3. Diphtheria.

4. Whooping cough.

5. Tetanus.

6. Polio.

7. Disease caused by Haemophilus influenzae type b.

8. Measles.

9. Rubella.

10. Japanese encephalitis.

11. Rotavirus diarrhea.

12. Pneumococcal disease.

13. Diseases caused by the HPV (Human Papilloma Virus) in humans.

14. Other diseases as prescribed by the Minister of Health .

Circular 13/2026/TT-BYT also regulates the organization of routine immunization, catch-up immunization, proactive immunization campaigns, and epidemic control immunization; the information and reporting regime on immunization activities; the management of immunization subjects; and the Professional Advisory Council for evaluating the causes of severe adverse events during the use of vaccines and biological products.

List of diseases requiring mandatory use of vaccines and biological products in epidemic control immunization.

1. Diphtheria.

2. Polio.

3. Whooping cough.

4. Rubella.

5. Measles.

6. Cholera.

7. Japanese encephalitis.

8. Rabies.

9. Influenza.

10. COVID-19.

11. Other infectious diseases as recommended by the World Health Organization and decided by the Minister of Health.

How should serious adverse events occurring during vaccination be handled?

Circular 13 also clarifies that vaccination must follow these steps: Before vaccination, conduct pre-vaccination screening according to the professional guidelines of the Minister of Health;

During vaccination: follow the vaccination schedule correctly; use each type of vaccine and biological product according to the manufacturer's instructions; ensure vaccination safety according to the professional guidelines of the Department of Disease Prevention and Control;

After vaccination: monitor the vaccinated individual at the vaccination site for at least 30 minutes; instruct parents or guardians or legal representatives (in the case of children, persons with diminished civil capacity, persons with limited civil capacity) to continue monitoring at home for at least 24 hours; record vaccination information according to the professional guidelines of the Department of Disease Prevention.

Regarding the handling of serious adverse events occurring during vaccination sessions, according to the guidelines of Circular 13, the vaccination session should be immediately stopped for emergency treatment and preliminary assessment of the cause of the serious adverse event; if the situation exceeds the capabilities of the relevant authorities, the person experiencing the serious adverse event must be transferred to an appropriate medical facility for examination and treatment.

Compile complete information regarding severe adverse events in accordance with the professional guidelines of the Department of Disease Prevention and Control, and report as required.

Circular 13 provides guidance on temporarily suspending the use of vaccine batches, biological products, etc.

Healthcare facilities that receive cases of severe adverse reactions after vaccination must provide emergency care and treatment and report the incidents as required.

The suspension of the use of vaccine and biological product batches is carried out as follows: For compulsory and voluntary immunization, if the Provincial/City Professional Advisory Council assesses the cause of severe adverse events during the use of vaccines and biological products and preliminarily determines that the cause of the severe adverse event after immunization is due to the quality of the vaccine or biological product, the head of the specialized health agency under the Provincial People's Committee must issue a written decision to temporarily suspend the use of that batch of vaccine or biological product within their jurisdiction after obtaining written approval from the Ministry of Health.

When the Council concludes that the cause of a serious adverse event is not related to the quality of the vaccine or biological product, the head of the specialized health agency under the Provincial People's Committee reports to the Ministry of Health and decides to allow the reuse of that batch of vaccine or biological product after obtaining written consent from the Ministry of Health;

Circular 13/2026/TT-BYT takes effect from July 1, 2026. Simultaneously, from this date, Circulars 24/2018/TT-BYT, 34/2018/TT-BYT, 05/2020/TT-BYT, and 52/2025/TT-BYT cease to be in effect.

Source: https://suckhoedoisong.vn/tu-1-7-nhung-benh-nao-phai-tiem-chung-bat-buoc-169260520001638609.htm